News Summary

IXI, a Helsinki-based startup, has raised $36.5 million in Series A funding to develop innovative prescription glasses featuring autofocus technology. This funding round, led by London-based Plural, includes contributions from the Amazon Alexa Fund and other notable investors such as Tesi, byFounders, Heartcore, and Eurazeo. IXI aims to revolutionize the eyewear market by integrating eye-tracking and liquid crystal lens technology, allowing the glasses to automatically adjust to correct presbyopia, a common form of farsightedness. The startup’s founders, Niko Eiden and Ville Miettinen, both have extensive backgrounds in advanced optics and eye-tracking technologies, having previously worked on mobile technology at Nokia and the mixed-reality headset company Varjo. This funding will support IXI’s goal to launch the world’s first autofocus glasses, offering a seamless and technologically advanced alternative to traditional bifocals and progressive lenses. The company envisions these glasses being priced similarly to high-end consumer electronics, aiming to cater to a broad market of vision-impaired consumers. IXI is currently working on finalizing the product for market launch, with prototypes expected later this year.